Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-22T13:06:32.104Z Has data issue: false hasContentIssue false
  • English
  • Français

Dextromethorphan/bupropion: a novel oral NMDA (N-methyl-d-aspartate) receptor antagonist with multimodal activity—Addendum

Published online by Cambridge University Press:  27 November 2019

Stephen M. Stahl
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Addendum
Information
CNS Spectrums , Volume 25 , Issue 6 , December 2020 , pp. 803
Copyright
© Cambridge University Press 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Stahl, SM. Dextromethorphan/bupropion: a novel oral NMDA (N-methyl-d-aspartate) receptor antagonist with multimodal activity. CNS Spectr. 2019; 24(5):461–466. doi:10.1017/S1092852919001470.CrossRefGoogle ScholarPubMed